If 340B Helps, Why Are Hospitals Fighting Transparency?

The 340B program aims to stretch healthcare dollars by offering steep discounts on medications to providers, which they are supposed to pass on to patients in need. Despite its potential benefits, hospitals are fiercely resisting efforts to increase transparency around how these discounts are applied. This pushback raises questions about whether the program's intended benefits are being fully realized, as critics argue that lack of transparency could undermine trust and the program's effectiveness in aiding vulnerable patients. Understanding this conflict is crucial for grasping the broader issues around healthcare pricing and patient access.